BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36012662)

  • 1. Exploring the Antitumor Potential of Copper Complexes Based on Ester Derivatives of Bis(pyrazol-1-yl)acetate Ligands.
    Pellei M; Santini C; Bagnarelli L; Battocchio C; Iucci G; Venditti I; Meneghini C; Amatori S; Sgarbossa P; Marzano C; De Franco M; Gandin V
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Silver Complexes Based on Phosphanes and Ester Derivatives of Bis(pyrazol-1-yl)acetate Ligands Targeting TrxR: New Promising Chemotherapeutic Tools Relevant to SCLC Management.
    Pellei M; Santini C; Bagnarelli L; Caviglia M; Sgarbossa P; De Franco M; Zancato M; Marzano C; Gandin V
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntheses and Biological Studies of Cu(II) Complexes Bearing Bis(pyrazol-1-yl)- and Bis(triazol-1-yl)-acetato Heteroscorpionate Ligands.
    Pellei M; Gandin V; Marchiò L; Marzano C; Bagnarelli L; Santini C
    Molecules; 2019 May; 24(9):. PubMed ID: 31067640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses and biological studies of nitroimidazole conjugated heteroscorpionate ligands and related Cu(I) and Cu(II) complexes.
    Pellei M; Gandin V; Cimarelli C; Quaglia W; Mosca N; Bagnarelli L; Marzano C; Santini C
    J Inorg Biochem; 2018 Oct; 187():33-40. PubMed ID: 30053534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cu(I) and Cu(II) Complexes Based on Lonidamine-Conjugated Ligands Designed to Promote Synergistic Antitumor Effects.
    Del Bello F; Pellei M; Bagnarelli L; Santini C; Giorgioni G; Piergentili A; Quaglia W; Battocchio C; Iucci G; Schiesaro I; Meneghini C; Venditti I; Ramanan N; De Franco M; Sgarbossa P; Marzano C; Gandin V
    Inorg Chem; 2022 Mar; 61(12):4919-4937. PubMed ID: 35285628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potent anticancer copper(ii) complexes containing tripodal bis[2-ethyl-di(3,5-dialkyl-1H-pyrazol-1-yl)]amine moiety.
    Massoud SS; Louka FR; Dial MT; Malek AJ; Fischer RC; Mautner FA; Vančo J; Malina T; Dvořák Z; Trávníček Z
    Dalton Trans; 2021 Sep; 50(33):11521-11534. PubMed ID: 34346447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.
    Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C
    Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Cytotoxic Activity Evaluation of New Cu(I) Complexes of Bis(pyrazol-1-yl) Acetate Ligands Functionalized with an NMDA Receptor Antagonist.
    Pellei M; Bagnarelli L; Luciani L; Del Bello F; Giorgioni G; Piergentili A; Quaglia W; De Franco M; Gandin V; Marzano C; Santini C
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper(II) complexes based on tripodal pyrazolyl amines: Synthesis, structure, magnetic properties and anticancer activity.
    Massoud SS; Louka FR; Ducharme GT; Fischer RC; Mautner FA; Vančo J; Herchel R; Dvořák Z; Trávníček Z
    J Inorg Biochem; 2018 Mar; 180():39-46. PubMed ID: 29232637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper-Based Complexes with Adamantane Ring-Conjugated
    Morelli MB; Caviglia M; Santini C; Del Gobbo J; Zeppa L; Del Bello F; Giorgioni G; Piergentili A; Quaglia W; Battocchio C; Bertelà F; Amatori S; Meneghini C; Iucci G; Venditti I; Dolmella A; Di Palma M; Pellei M
    J Med Chem; 2024 Jun; 67(11):9662-9685. PubMed ID: 38831692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
    Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
    J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands.
    Porchia M; Benetollo F; Refosco F; Tisato F; Marzano C; Gandin V
    J Inorg Biochem; 2009 Dec; 103(12):1644-51. PubMed ID: 19822369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper (II) complexes possessing alkyl-substituted polypyridyl ligands: Structural characterization and in vitro antitumor activity.
    Angel NR; Khatib RM; Jenkins J; Smith M; Rubalcava JM; Le BK; Lussier D; Chen ZG; Tham FS; Wilson EH; Eichler JF
    J Inorg Biochem; 2017 Jan; 166():12-25. PubMed ID: 27815978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NN'O] ligands: Synthesis, characterization, structural investigations and antiproliferative activity.
    Amiri Rudbari H; Saadati A; Aryaeifar M; Blacque O; Cuevas-Vicario JV; Cabral R; Raposo LR; Fernandes AR
    Bioorg Chem; 2022 Feb; 119():105556. PubMed ID: 34959175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed-valence copper(I,II) complexes with 4-(1H-pyrazol-1-yl)-6-R-pyrimidines: from ionic structures to coordination polymers.
    Vinogradova KA; Krivopalov VP; Nikolaenkova EB; Pervukhina NV; Naumov DY; Boguslavsky EG; Bushuev MB
    Dalton Trans; 2016 Jan; 45(2):515-24. PubMed ID: 26600314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tripodal bis(imidazole) thioether copper(I) complexes: mimics of the Cu(M) site of copper hydroxylase enzymes.
    Zhou L; Powell D; Nicholas KM
    Inorg Chem; 2007 Sep; 46(19):7789-99. PubMed ID: 17713902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dinuclear doubly bridged phenoxido copper(II) complexes as efficient anticancer agents.
    Massoud SS; Louka FR; Salem NMH; Fischer RC; Torvisco A; Mautner FA; Vančo J; Belza J; Dvořák Z; Trávníček Z
    Eur J Med Chem; 2023 Jan; 246():114992. PubMed ID: 36525695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutral and charged phosphine/scorpionate copper(I) complexes: effects of ligand assembly on their antiproliferative activity.
    Porchia M; Dolmella A; Gandin V; Marzano C; Pellei M; Peruzzo V; Refosco F; Santini C; Tisato F
    Eur J Med Chem; 2013 Jan; 59():218-26. PubMed ID: 23229057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ synthesis of mononuclear copper(II) complexes of the new tridentate ligand bis[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]amine.
    Yu F
    Acta Crystallogr C; 2011 Oct; 67(Pt 10):m331-4. PubMed ID: 21979969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Investigations of the Antitumor Effects of First-Row Transition Metal(II) Complexes Supported by Two Fluorinated and Non-Fluorinated β-Diketonates.
    Pellei M; Del Gobbo J; Caviglia M; Gandin V; Marzano C; Karade DV; Noonikara Poyil A; Dias HVR; Santini C
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.